ERYTHROPOIETIC PROTOPORPHYRIA (EPP)

Clinical trials for ERYTHROPOIETIC PROTOPORPHYRIA (EPP) explained in plain language.

Never miss a new study

Get alerted when new ERYTHROPOIETIC PROTOPORPHYRIA (EPP) trials appear

Sign up with your email to follow new studies for ERYTHROPOIETIC PROTOPORPHYRIA (EPP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug could let Sunlight-Sensitive patients enjoy the outdoors again

Disease control Recruiting now

This study is testing whether an investigational drug called bitopertin can help people with rare genetic conditions (EPP or XLP) that cause severe pain from sunlight exposure. Researchers want to see if taking bitopertin for 6 months allows participants to spend more time in the…

Matched conditions: ERYTHROPOIETIC PROTOPORPHYRIA (EPP)

Phase: PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control

Last updated Mar 27, 2026 12:47 UTC

ERYTHROPOIETIC PROTOPORPHYRIA (EPP)

Get alerted when new ERYTHROPOIETIC PROTOPORPHYRIA (EPP) trials appear

New drug could let Sunlight-Sensitive patients enjoy the outdoors again